mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0004 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0004 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0006 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0007 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0008 |
mRNA |
XL-184 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |